SOCIOCLINICAL CORRELATES AND RISK FACTORS ASSOCIATED WITH MULTIDRUGRESISTANT TUBERCULOSIS IN A TERTIARY CARE CENTER IN GANJAM, ODISHA
DOI:
https://doi.org/10.22159/ajpcr.2025v18i8.55324Keywords:
Multidrug-resistant tuberculosis, Socioclinical profile, Ganjam, Tuberculosis, Drug resistance, Public Health.Abstract
Objectives: The purpose of the study is to assess the socioclinical profile of multidrug-resistant tuberculosis (MDR-TB) cases admitted to a tertiary care hospital in Ganjam.
Methods: A cross-sectional study was conducted among the MDR-TB patients admitted to the indoor DR-TB ward of the Department of Pulmonary Medicine of MKCG Medical College and Hospital, Berhampur, from October 2023 to October 2024. Data were collected with the help of a questionnaire, which comprised information on socioclinical characteristics of the study participants. The data were tabulated by MS-Excel v.21 and then analyzed using statistical software like JAMOVI v.2.6.13.
Results: Among 103 MDR-TB patients who consented to participate in the study, the majority were males of 20–40 years. Mostly, study participants were educated in primary school, belonged to the lower-middle class, and engaged in semi-skilled occupations. 93% of the patients admitted presented with cough followed by expectoration (69%), fever (68%), vomiting (67%), hemoptysis (35%), etc. Among the co-morbidities reported, the majority were chronic obstructive pulmonary disease (COPD), followed by diabetes mellitus, hypertension, and HIV/AIDS, respectively.
Conclusion: MDR-TB remains a major health problem in Ganjam, which is mainly influenced by low socioeconomic status, conditions like overcrowding, and various clinical conditions such as COPD, hypertension, HIV, and diabetes mellitus. These comorbidities complicate the clinical management of MDR-TB and may influence treatment outcomes. A comprehensive, patient-centered approach involving the diagnosis and management of coexisting illnesses is essential for achieving better therapeutic results.
Downloads
References
1. Park K, Jabalpur MP, editor. Park’s Textbook of Preventive and Social Medicine. 27th ed. India: M/S Banarsidas Bhanot; 2023. p. 208.
2. World Health Organization, Klaudt K, editor. TB a Global Emergency WHO/TB/94.177. Geneva: World Health Organization; 1994. p. 1-28. Available from: https://www.ncbi.nlm.nih.gov/ pubmed/8683910
3. Mahmood A. Multi-drug resistant tuberculosis. J Pak Med Assoc. 2001;51(5):204-5. PMID 11467247
4. The WHO, IUATLD. Global Project on Anti-Tuberculosis Drug Resistance Surveillance: Anti-Tuberculosis Resistance in the World. Prevalence Trends: Report No. 2. Geneva: World Health Organization; 2000. p. 20-5.
5. RNTCP. TB India 2016 Revised National TB Control Programme Annual Status Report. New Delhi; 2016. Available from: https://www. tbcindia.nic.in
6. Kushwaha V, Agrawal P, Tripathi MK, Kumar A, Verma AK, Sharma H. A cross-sectional study to assess the pharmacotherapeutic adherence in patients attending the outpatient department of respiratory medicine in a tertiary care hospital. Int J Pharm Pharm Sci. 2022 Jun;114(6):9-16. doi: 10.22159/ijpps.2022v14i6.44378
7. Batra S, Ayaz A, Murtaza A, Ahmad S, Hasan R, Pfau R. Childhood tuberculosis in household contacts of newly diagnosed TB patients. PLoS One. 2012;7(7):e40880.
8. Drug-Resistant TB. World Health Organization. Available from: https:// www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2024/tb-disease-burden/1-3-drug-resistant-tb
9. Tuberculosis (TB). Central TB Division. NHM; 2024. p. 11-2. Available from: https://www.who.int/news-room/fact-sheets/detail/ tuberculosisindia
10. Janssens JP, Rieder HL. An ecological analysis of incidence of tuberculosis and per capita gross domestic product. Eur Respir J. 2008 Nov;32(5):1415-6.doi: 10.1183/09031936.00078708, PMID 18978146
11. Wijayanto MA, Arnanda RA, Thamrin EP. Risk factors for development of multidrug-resistant tuberculosis among relapsed patients in West Papua, Indonesia: A descriptive and analytical study. Int J App Pharm. 2019 Dec 15;11(6):50-5.
12. Bhatt G, Vyas S, Trivedil K. An epidemiological study of multi drug resistant tuberculosis cases registered under the revised national tuberculosis control programme of Ahmedabad city. Indian J Tuberc. 2012 Jan;59(1):18-27. PMID 22670507
13. Workicho A, Kassahun W, Alemseged F. Risk factors for multidrug-resistant tuberculosis among tuberculosis patients: A case-control study. Infect Drug Resist. 2017;10:91-6. doi: 10.2147/IDR.S126274, PMID 28331350
14. Gaude GS, Hattiholli J, Kumar P. Risk factors and drug-resistance patterns among pulmonary tuberculosis patients in northern Karnataka region, India. Niger Med J. 2014;55(4):327-32. doi: 10.4103/0300- 1652.137194, PMID 25114369
15. Atre SR, D’Souza DT, Vira TS, Chatterjee A, Mistry NF. Risk factors associated with MDR-TB at the onset of therapy among new cases registered with the RNTCP in Mumbai, India. Indian J Public Health. 2011;55(1):14-21. doi: 10.4103/0019-557X.82536, PMID 21727675
16. Mulu W, Mekonnen D, Yimer M, Admassu A, Abera B. Risk factors for multidrug resistant tuberculosis patients in Amhara national regional state. Afr Health Sci. 2015 Jun;15(2):368-77. doi: 10.4314/ahs.v15i2.9, PMID 26124781
Published
How to Cite
Issue
Section
Copyright (c) 2025 Dr. Sanjaya Kumar Sahoo

This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.